Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -24.2% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 6.2 | n/a |
| Pr/Book | 3.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 283.7% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-21 | n/a | (1.50) | (0.01)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-22 | 0.07 | (2.99) | (1.78)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-23 | 0.13 | (3.01) | (1.72)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-24 | 1.21 | (2.95) | (1.54)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-25 | 4.64 | (0.72) | (0.31)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Holding(s) in Company | 21-Jul-2026 | 07:00 | RNS |
| IMC Presentation Statement | 29-Jun-2026 | 07:00 | RNS |
| Directorate change | 25-Jun-2026 | 12:00 | RNS |
| Skinbiotherapeutics brings in new audit chair, l... | 20-Feb-2026 | ShareCast |
| SkinBioTherapeutics dives on warning of major FY... | 16-Feb-2026 | ShareCast |
| SkinBioTherapeutics CEO resigns | 13-Feb-2026 | ShareCast |
| SkinBioTherapeutics dives after sudden exit of c... | 18-Feb-2026 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 12.25p |
| Change Today | 1.00p |
| % Change | 8.89 % |
| 52 Week High | 12.80 |
| 52 Week Low | 11.00 |
| Volume | 1,096,308 |
| Shares Issued | 259.04m |
| Market Cap | £31.73m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:40 | 325,000 @ 12.27p |
| 16:04 | 11,973 @ 12.12p |
| 15:46 | 60 @ 12.12p |
| 15:42 | 8,048 @ 12.30p |
| 15:41 | 4,147 @ 12.11p |
You are here: research